Skip to main content

2010 Divisional Bibliography

Peer Reviewed

  1. Agarwal R, Weir MR. Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients. Clin J Am Soc Nephrol. 2010 Jul;5(7):1255-60.
  2. Bakris GL, Sarafidis PA, Weir MR, Dahlof B, et al. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomized controlled trial. Lancet. 2010 Apr 3;375(9721):1173-81.
  3. Bie, B., Zhang, Z., Zhu, W., Zhang, Y., Dai, J., Lowenstein, C., Weinman, E.J., and Pan, Z.: Nerve Growth Factor-Regulated Emergence of Functional Delta-Opioid Receptors. J. Neurosci. 2010;30:5617-5628,.
  4. Cao C, Edwards A, Sendeski M, Lee-Kwon W, Cui L, Cai CY, Patzak A, Pallone TL. Intrinsic nitric oxide and superoxide production regulates descending vasa recta contraction. Am J Physiol Renal Physiol 2010 November;299(5):F1056-F1064.
  5. Chambers JC, Zhang W, Lord GM, van der Harst P, Lawlor DA, Sehmi JS, Gale DP, Wass MN, Ahmadi KR, Bakker SJ, Beckmann J, Bilo HJ, Bochud M, Brown MJ, Caulfield MJ, Connell JM, Cook HT, Cotlarciuc I, Smith GD, de Silva R, Deng G, Devuyst O, Dikkeschei LD, Dimkovic N, Dockrell M, Dominiczak A, Ebrahim S, Eggermann T, Farrall M, Ferrucci L, Floege J, Forouhi NG, Gansevoort RT, Han X, Hedblad B, van der Heide JJ, Hepkema BG, Hernandez-Fuentes M, Hypponen E, Johnson T, de Jong PE, Kleefstra N, Lagou V, Lapsley M, Li Y, Loos RJ, Luan J, Luttropp K, Maréchal C, Melander O, Munroe PB, Nordfors L, Parsa A, et al. Genetic loci influencing kidney function and chronic kidney disease. Nat Genet. 2010(42):373-375.
  6. Chapin E, Zhan M, Hsu VD, Seliger SL, Walker LD, Fink JC. Adverse safety events in chronic kidney disease: the frequency of “multiple hits”. Clin J Am Soc Nephrol; 2010(5): 87-94.
  7. Cunningham, R., Biswas, R., Steplock, D., Shenolikar, S., and Weinman, E.J.: Role of NHERF and scaffolding proteins in proximal tubule transport. Urol. Res. 2010(38):257-262.
  8. DeFilippi CR, Christenson RG,. Gottdiener JS, Kop WJ, Seliger SL. Dynamic Cardiovascular Risk Assessment in Elderly People: The Role of Repeated N-Terminal Pro–B-Type Natriuretic Peptide Testing. J Am Coll Cardiol, 2010: 55(5):441-450.
  9. DeFilippi CR, deLemos JA, Christenson RH, Gottdiener JS, Kop WJ, Seliger SL.  Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010; 304(22).
  10. DeSilva L, Weir MR. Renin inhibition and microalbuminuria development: meaning predictor of kidney disease progression.  Curr Opin Nephrol Hypertens. 2010 Sep;19(5):437-43.
  11. Donowitz, M., Singh, S., Singh, P., Salahuddin, F.F., Chen, Y., Chakraborty, M., Murtazina, R.,  Gucek, M., Cole, R.N., Zachos, N.C., Kovbasnjuk, O., Lapierre, L.A., Ham, A.,  Broere, N., Smalley, W.G.,  Reynolds, A.B., Hubbard, A.L., Goldenring, J., Seidler, U.,  Weinman, E. J.,  de Jonge, H.R., and Hogema, B.M, Li, X.: Alterations in the Proteome of the NHERF1 Knockout Mouse Jejunal Brush Border Membrane Vesicles. Physiol. 2010(42):200-210.
  12. Edwards A, Cao C, Pallone T.  Cellular mechanisms underlying nitric oxide induced vasodilation of descending vasa recta.  Am J Physiol Renal Physiol. 2010 [Epub ahead of print] PMID: 21084408
  13. Evan, A.P., Weinman, E.J., Wu, X., Lingeman, J.E., Worcester, E.M., and Coe. F.L.: Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP null mice. Urol. Res. 2010(38):439-452.
  14. Fink JC, Lodge MA, Smith MF, Hinduja A, Brown J, Dinits-Pensy MY, Dilsizian V. Pre-Clinical Myocardial Metabolic Alterations in Chronic Kidney Disease. Cardiology. 2010(116):160-167.
  15. Gradman AH, Weir MR, Wright M, Bush CA, Keefe DL. Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies. J Hum Hypertens. 2010 Nov; 24(11):721-9.
  16. Grunwald, JE, Alexander J, Maguire M, Whittock R, Parker C, McWilliams K, Lo JC, Townsend R, Gadegbeku CA., Lash JP, Fink JC, Rahman M., Feldman H, Kusek J, Ojo,A,. The CRIC Study Group. Prevalence of Ocular Fundus Pathology in Subjects with Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.  Clin J Am Soc Nephrol; 2010 (5):867-73.
  17. Haririan A, Nogueira JM, Zandi-Nejad K, Aiyer R, Hurley H, Cooper M, Klassen DK, Weir MR. The independent association between serum uric acid and graft outcomes after kidney transplantation. Transplantation. 2010 Mar 15; 89(5):573-9.
  18. Joffe, M, Hsu, C, Feldman, HI, Weir M, Landis Jr., et al. Variability of Creatinine Measurements in Clinical Laboratories: Results from the CRIC Study.  Am J Nephrol 2010; 31:426-434. DOI: 10.1159/000296250.
  19. Kiangkitiwan B, Haririan A. Invited commentary on low high-density lipoprotein is a risk for vascular disease. Transpl Int. 2010 Jun; 23(6):571-3.
  20. Köttgen A, Pattaro C, Böger C.A., Fuchsberger C, Olden M, Glazer N.L., Parsa A, et al. New Loci Associated with Kidney Function and Chronic Kidney Disease. Nat Genet. 2010; 42: 376-384.  
  21. Lattanzio MR, Weir MR. Does blockade of the Renin-Angiotensin-aldosterone system slow progression of all forms of kidney disease? Curr Hypertens Rep. 2010 Oct; 12(5):369-77.
  22. Lattanzio MR, Weir MR. Have we fallen off target with concerns surrounding dual RAAS blockade? Kidney Int. 2010 Sep; 78(6):539-45.
  23. Lawler EV, Gagnon DR, Fink J, Seliger S, Fonda J, Do TP, Gaziano JM, Bradbury BD. Initiation of anaemia management in patients with chronic kidney disease not on dialysis in the Veterans Health Administration. Nephrol Dial Transplant; 2010 (25): 2237-2244.
  24. Li, M., Wang, W., Soroka, C.J., Mennone, A., Harry, K., Weinman, E.J., and Boyer, J.L.: NHERF-1 binds to Mrp2 and regulates hepatic Mrp2 expression and function. J. Biol. Chem. 2010; 285:19299-19307.
  25. Lin H, Pallone TL, Cao C. Murine vasa recta pericyte chloride conductance is controlled by calcium, depolarization, and kinase activity. Am J Physiol Regul Integr Comp Physiol 2010 November; 299(5):R1317-R1325.
  26. Manitpisitkul W, Wilson NS, Haririan A. Immunosuppressive agents as risk factors for BK virus nephropathy: an overview and update. Expert Opin Drug Saf. 2010 Nov; 9(6):959-69.
  27. Munivenkatappa R, Haririan A, Papadimitriou JC, Drachenberg CB, Dinits-Pensy M, Klassen DK. Tubular epithelial cell and podocyte apoptosis with de novo sirolimus based immunosuppression in renal allograft recipients with DGF. Histol Histopathol. 2010 Feb; 25(2):189:96.
  28. Muntner P, Anderson A, Charleston J, Chen Z, Ford V, Makos G, O’Connor A, Perumal K, Rahman M, Steigerwalt S, Teal V, Townsend R, Weir MR, et al. Hypertension Awareness, Treatment, and Control in Adults With CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2010 Mar; 55(3):441-51.
  29. Nogueira JM, Weir MR, Jacobs S, Breault D, Klassen D, Evans DA, Bartlett ST, Cooper M. A study of renal outcomes in obese living kidney donors. Transplantation. 2010 Nov 15; 90(9):993-9.
  30. Nogueira JM, Haririan A, Jacobs SC, Cooper M, Weir MR. Cigarette smoking, kidney function, and mortality after live donor kidney transplant. Am J Kidney Dis. 2010 May; 55(5):907-15.
  31. Onukwugha E, Saunders E, Mullins CD, Pradel FG, Zuckerman M, Weir MR.   Reasons for discharges against medical advice: a qualitative study. Qual Saf Health Care. 2010 (19):420-424.
  32. Papadimitriou JC, Drachenberg CB, Munivenkatappa R, Ramos E, Nogueira J, Sailey C, Klassen DK, Haririan A. Glomerular inflammation in renal allografts biopsies after the first year: cell types and relationships with antibody-mediated rejection and graft outcome. Transplantation. 2010 Dec 27;90(12):1478-85.
  33. Parsa A. Genotype-Phenotype Correlations: Filling the Void. Clin J Am Soc Nephrol. 2010 Sep;5(9):1542-3.
  34. Roth I, Leroy V, Kwon HM, Martin PY, Feraille E, Hasler U. The osmoprotective transcription factor NFAT5/TonEBP modulates NFkB activity. Mol Cell Biol 2010 (21):3459-74. PMID: 20685965.
  35. Russell M, Silverman A, Fleg JL, Lee ET, Mete M, Weir M, Wilson C, Yeh F, Howard BV, Howard WM. Achieving lipid targets in adults with type 2 diabetes: the Stop Atherosclerosis in Native Diabetics Study. J Clin Lipidol. 2010 Sep-Oct;4(5):435-43.
  36. Seliger SL, Fox KM, Gandra SR, Bradbury B, Hsu VD, Walker LM, Chiou CF, Fink JC.  Timing of Erythropoiesis-stimulating agent (ESA) initiation and adverse outcomes in non-dialysis CKD: a propensity-matched observational study Clin J Am Soc Nephrol; 2010 (5): 882-8.
  37. Semba RD, Fink JC, Sun K, Windham BG, Ferrucci L.  Serum Carboxymethyl-Lysine, a Dominant Advanced Glycation End Product, Is Associated With Chronic Kidney Disease: The Baltimore Longitudinal Study of Aging. J Ren Nutr; 2010 20: 74-81.
  38. Stevens LA, Schmid CH, Zhang YL, Coresh J, Manzi J, Landis R, Bakoush O, Contreras G, Genuth S, Klintmalm GB, Poggio E, Rossing P, Rule AD, Weir MR, et. al. Development and validation of GFR-estimating equations using diabetes, transplant and weight. Nephrol Dial Transplant. 2010 Feb;25(2):449-57.
  39. Szczech LA, Granger CB, Dasta JF, Amin A, Peacock WF, McCullough PA, Devlin JW, Weir MR, et al. Acute kidney injury and cardiovascular outcomes in acute severe hypertension.  Circulation. 2010 May 25;121(20):2183-91.
  40. Townsend RR, Chirinos JA, Parsa A, Weir MR, Sozio SM, Lash JP, et al. Central pulse pressure in chronic kidney disease: a chronic renal insufficiency cohort ancillary study. Hypertension. 2010 Sep;56(3):518-24.
  41. Townsend RR, Wimmer NJ, Chirinos JA, Parsa A, Weir M, Perumal K, et al. Aortic PWV in chronic kidney disease: a CRIC ancillary study. Am J Hypertens. 2010 Mar;23(3):282-9.
  42. Waldstein SR, Wendell CR, Seliger SL, Ferrucci L, Metter EJ, Zonderman AB.  Nonsteroidal anti-inflammatory drugs, aspirin, and cognitive function in the Baltimore longitudinal study of aging. J Am Geriatr Soc. 2010 Jan; 58(1):38-43. 
  43. Wali RK, Lyengar M, Beck GJ, Chartyan DM, Chonchol M, Lukas MA, Cooper C, Himmelfarb J, Weir MR, Berl T, Henrich WL, Cheung AK. Efficacy and Safety of Carvediolol in Treatment of Heart Failure in Chronic Kidney Disease: A Meta-Analysis of Randomized Trials. Circ Heart Fail. 2010 Oct 29.[Epub ahead of print]
  44. Weber MA, Bakris GL, Jamerson K, Weir M, Kjeldsen SE, et. al. Cardiovascular events during differing hypertension therapies in patients with diabetes. J Am Coll Cardiol. 2010 Jun 29;56(1):77-85.
  45. Weinman, E.J., Biswas, R., Steplock, S., Douglas, T., Cunningham, R., and Shenolikar, S.: Sodium-hydrogen exchanger regulatory factor-1 (NHERF-1) transduces signals that mediate dopamine inhibition of sodium-phosphate co-transport in mouse kidney. J. Biol. Chem. 2010(285):13454-13460.
  46. Weinman, E.J., Steplock, D., Zhang, Y., Biswas, R., Bloch, R.J., and Shenolikar, S.: Cooperativity between the phosphorylation of Thr95 and Ser77 of NHERF-1 in the hormonal regulation of Renal Phosphate transport. J. Biol. Chem. 2010 (285):25134-25138,.
  47. Weinrauch LA, Sun J, Gleason RE, Boden GH, Creech RH, Dailey G, Kennedy FP, Weir MR, D’Elia JA. Pulsatile intermittent intravenous insulin therapy for attenuation of retinopathy and nephropathy in type 1 diabetes mellitus. Metabolism. 2010 Oct;59(10):1429-34.
  48. Weir MR, Diekmann F, Flechner SM, Lebranchu Y, Mandelbrot DA, et al. mTOR inhibition: the learning curve in kidney transplantation. Transpl Int. 2010 May 1;23(5):447-60.
  49. Weir MR. Can the early elimination of calcineurin inhibitors result in clinical benefits? Transplant Proc. 2010 Nov; 42(9):S16-20.
  50. Weir MR, Bakris GL. Optimal blood pressure for a patient with type 2 diabetes mellitus: insight from the ACCORD study. Curr Hypertens Rep. 2010 Oct;12(5):313-5.
  51. Weir MR. Hypervolemia and blood pressure: powerful indicators of increased mortality among hemodialysis patients. Hypertension. 2010 Sep;56(3):341-3.
  52. Weir MR, Yadao AM, Purkayastha D, Charney AN. Effects of High-and Low-Sodium Diets on Ambulatory Blood Pressure in Patient With Hypertension Receiving Aliskiren. J Cardiovasc Pharmacol Ther. 2010 Dec;15 (4):356-63.
  53. Weir MR. Dietary fructose and elevated levels of blood pressure. J Am Soc Nephrol. 2010 Sept;21(9):1416-8.
  54. Weir MR, Zappe D, Orloski LA, Sowers JR. How early should blood pressure control be achieved for optimal cardiovascular outcomes? J Hum Hypertens. 2010 Jul 1. [Epub ahead of print]
  55. Weir MR. Hypertension: Endothelin-receptor antagonists for treating hypertension. Nat Rev Nephrol. 2010 Apr;6(4):192-4.
  56. Weir MR, Rolfe M. Potassium hemeostasis and renin-angiotensin-aldosterone system inhibitors. Clin J Am Soc Nephrol. 2010 Mar;5(3):531-48.
  57. Weir MR. Relative plasma volume monitoring and blood pressure control: an overlooked opportunity to achieve dry weight in the hemodialysis patient. Hypertension. 2010 Feb;55(2):226-7.
  58. Weir MR, Hollenberg NK, Zappe DH, Meng X, Parving HH, Viberti G, Remuzzi G. Antihypertensive effects of double the maximum dose of valsartan in African-American patients with type 2 diabetes mellitus and albuminuria. J Hypertens. 2010 Jan;28(1):186-93.
  59. Weir MR, Bogle LL, Mackowiak PA. The Death of John Paul Jones and Resurrection as ‘Father of the US Navy’. Am J Nephrol. 2010;31(1):90-4.
  60. Weir MR, Bakris GL. Editorial perspective.  Should microalbuminuria ever be considered as a renal endpoint in any clinical trial? Am J Nephrol. 2010;31(5):469-70.
  61. Wilson C, Huang CC, Shara N. Howard BV, Fleg JL, Henderson JA, Howard WJ, Huentelman H, Lee ET, Mete M, Russell M, Galloway JM, Silverman A, Stylianou M, Umans J, Weir MR, Yeh F, Ratner RE. Cost-effectiveness of lower targets for blood pressure and LDL cholesterol in diabetes: the stop atherosclerosis in native diabetics study (SANDS). J Clin Lipidol. 2010 May;4(3):165-172.
  62. Yaffe K, Ackerson L, Tamura MK, Le Blanc P, Kusek JW, Sehgal AR, Cohen D, Anderson C, Appel L, Desalvo K, Ojo A, Seliger S, Robinson N, Makos G, Go AS. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc 2010; 58(2): 338-45.
  63. Zhang Z, Lin H, Cao C, Khurana S, Pallone TL. Voltage-gated divalent currents in descending vasa recta pericytes. Am J Physiol Renal Physiol 2010 October; 299(4):F862-F871.

Non Peer-Reviewed

  1. Fink JC. The effect of CKD therapies on serum potassium levels. Nat Rev Nephrol; 2010 6:633-634.
  2. Seliger SL. Comorbidity and confounding in ESRD. Kidney Int, 2010;77(2):83-5.


  • Fink JC.  Chronic Kidney Disease as a Potent Risk Modifier for Coronary Heart Disease in Diabetes Mellitus.  JACC Cardiovasc Imaging; 2010; 3: 746-748.

Book Chapters

  • Hanes DS, Narakala NK, Weir MR. How Low Should Systolic and Diastolic Blood Pressure Be? In: Clinical Challenges, Hypertension II, ed Toth and Sica.  2010, 51-64.
  • Kotton CN, Ramos E. Renal Transplant Recipients. In: Himmelfarb, J and Sayegh MH.  Chronic Kidney Disease, Dialysis, and Transplantation: A Companion to Brenner and Rector’s the Kidney Expert Consult -3rd edition. Saunders. 2010, 553-67.
  • Waldstein SR, Wendell CR, Hosey MH, Seliger SL, Katzel LI. Cardiovascular Disease and Neurocognitive Function. In: Handbook of Medical Neuropsychology: Applications of Cognitive Neuroscience, Armstrong CL, Morrow L eds. New York: Springer Science-Business Medical LLC, 2010.
  • Weir MR, Brown EM. What is the optimal treatment in obesity-related hypertension? In: Weir, MR. Evidence-based Management of Hypertension.  Tfm Pub Ltd, Castle Hill Barns, Harley, Shrewsbury, UK, 2010. 29-40.


  • Weir MR.  Evidence-based Management of Hypertension. Tfm Pub Ltd, Castle Hill Barns, Harley, Shrewsbury, UK, 2010.